drugset / Trial / NCT05949632
A Study of INCB099280 in Combination With Axitinib in Adults With Advanced Solid Tumors
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This study is being conducted to evaluate the safety and tolerability of INCB099280 in combination with axitinib and to assess the antitumor activity of INCB099280 in combination with axitinib. This study will only be open in the UK and EU.
Timeline
- Start
- 2024-04-16
- Primary completion
- 2025-06-06
- Completion
- 2025-06-06
Outcome
Outcome not reported
Stopped (Business): “This was a strategic business decision. There were no safety concerns contributing to this decision.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | INCB099280 | Unknown | — | — |
| Background | Axitinib | Small molecule | — | — |